TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 21nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 24nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 25nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 31nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 53nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 53nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 64nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 85nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 110nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 130nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 238nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9 [134-239](Homo sapiens (Human))
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Genentech, Inc.; Constellation Pharmaceuticals Inc.
US Patent
Affinity DataIC50: 4.10E+3nMAssay Description:His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en...More data for this Ligand-Target Pair